IL-33 mediated amplification of allergic response in human mast cells

References

• Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23(5):479–490.
   PubMed Web of Science ®Google Scholar
• Préfontaine D, Nadigel J, Chouiali F, et al. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol. 2010;125(3):752–754.
   PubMed Web of Science ®Google Scholar
• Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’? PLoS One. 2008;3(10):e3331.
   PubMed Web of Science ®Google Scholar
• Cayrol C, Girard JP. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol. 2014;31:31–37.
   PubMed Web of Science ®Google Scholar
• Martin MU. Special aspects of interleukin-33 and the IL-33 receptor complex. Semin Immunol. 2013;25:449–457.
   PubMed Web of Science ®Google Scholar
• Braun H, Afonina IS, Mueller C, et al. Dichotomous function of IL-33 in health and disease: from biology to clinical implications. Biochem Pharmacol. 2018;148:238–252.
   PubMed Web of Science ®Google Scholar
• James AL, Wenzel S. Clinical relevance of airway remodelling in airway diseases. Eur Respir J. 2007;30(1):134–155.
   PubMed Web of Science ®Google Scholar
• Barksby HE, Lea SR, Preshaw PM, et al. The expanding family of interleukin‐1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol. 2007;149(2):217–225.
   PubMed Web of Science ®Google Scholar
• Modena BD, Dazy K, White AA. Emerging concepts: mast cell involvement in allergic diseases. Transl Res. 2016;174:98–121.
   PubMed Web of Science ®Google Scholar
• Hamzaoui A, Berraies A, Kaabachi W, et al. Induced sputum levels of IL-33 and soluble ST2 in young asthmatic children. J Asthma. 2013;50(8):803–809.
   PubMed Web of Science ®Google Scholar
• Byers DE, Alexander-Brett J, Patel AC, et al. Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest. 2013;123(9):3967–3982.
   PubMed Web of Science ®Google Scholar
• Shaw JL, Fakhri S, Citardi MJ, et al. IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps. Am J Respir Crit Care Med. 2013;188(4):432–439.
   PubMed Web of Science ®Google Scholar
• Smith DE. IL‐33: a tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin Exp Allergy. 2010;40(2):200–208.
   PubMed Web of Science ®Google Scholar
• Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol. 2010;10(2):103.
   PubMed Web of Science ®Google Scholar
• Jemima EA, Prema A, Thangam EB. Functional characterization of histamine H4 receptor on human mast cells. Mol Immunol. 2014;62(1):19–28.
   PubMed Web of Science ®Google Scholar
• Thangam EB, Jemima EA, Singh H, et al. The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: the hunt for new therapeutic targets. Front Immunol. 2018;9:1873.
   PubMed Web of Science ®Google Scholar
• Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012;18(5):693.
   PubMed Web of Science ®Google Scholar
• Guo Z, Wu J, Zhao J, et al. IL-33 promotes airway remodeling and is a marker of asthma disease severity. J Asthma. 2014;51(8):863–869.
   PubMed Web of Science ®Google Scholar
• Azazi EA, Elshora AE, Tantawy EA, et al. Serum levels of Interleukin-33 and its soluble receptor ST2 in asthmatic patients. Egypt J Chest Dis Tuberc. 2014;63(2):279–284.
   Google Scholar
• Rådingerm Jensen, BM, Kuehn, HS, et al. Generation, isolation, and maintenance of human mast cells and mast cell lines derived from peripheral blood or cord blood. Curr Protoc Immunol. 2010;90(1):7–37.
   Google Scholar
• Lloyd C. Chemokines in allergic lung inflammation. Immunology. 2002;105(2):144.
   PubMed Web of Science ®Google Scholar
• Wang SB, Deng YQ, Ren J, et al. Exogenous interleukin-10 alleviates allergic inflammation but inhibits local interleukin-10 expression in a mouse allergic rhinitis model. BMC Immunol. 2014;15(1):9.
   PubMed Web of Science ®Google Scholar
• Amin K. The role of mast cells in allergic inflammation. Respir Med. 2012;106(1):9–14.
   PubMed Web of Science ®Google Scholar
• Kaur D, Gomez E, Doe C, et al. IL‐33 drives airway hyper‐responsiveness through IL‐13‐mediated mast cell: airway smooth muscle crosstalk. Allergy. 2015;70(5):556–567.
   PubMed Web of Science ®Google Scholar
• Al C, Gallenga CE, Kritas SK, et al. Impact of mast cells in systemic lupus erythematosus: can inflammation be inhibited? J Biol Regul Homeost Agents. 2019;33(3):669–673.
   PubMed Web of Science ®Google Scholar
• Gallenga CE, Pandolfi F, Caraffa A, et al. Interleukin-1 family cytokines and mast cells: activation and inhibition. J Biol Regul Homeost Agents. 2019;33(1):1–6.
   PubMed Web of Science ®Google Scholar
• Gugliandolo A, Caraffa AL, Gallenga CE, et al. Mesenchymal stem cells and IL-37: a powerful combination. J Biol Regul Homeost Agents. 2019;33(4):1019–1022.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010;140(6):900–917.
   PubMed Web of Science ®Google Scholar
• Pushparaj PN, Tay HK, H'ng SC, et al. The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci USA. 2009;106(24):9773–9778.
   PubMed Web of Science ®Google Scholar
• Theoharides TC, Zhang B, Kempuraj D, et al. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci USA. 2010;107(9):4448–4453.
   PubMed Web of Science ®Google Scholar
• Sjöberg LC, Gregory JA, Dahlén SE, et al. Interleukin‐33 exacerbates allergic bronchoconstriction in the mice via activation of mast cells. Allergy. 2015;70(5):514–521.
   PubMed Web of Science ®Google Scholar
• Joulia R, L'Faqihi FE, Valitutti S, et al. IL-33 fine tunes mast cell degranulation and chemokine production at the single-cell level. J Allergy Clin Immunol. 2017;140(2):497–509.
   PubMed Web of Science ®Google Scholar
• Rönnberg E, Ghaib A, Ceriol C, et al. Divergent effects of acute and prolonged interleukin 33 exposure on mast cell IgE-mediated functions. Front Immunol. 2019;10:1361.
   PubMed Web of Science ®Google Scholar
• Iikura M, Suto H, Kajiwara N, et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest. 2007;87(10):971.
   PubMed Web of Science ®Google Scholar
• Allakhverdi Z, Smith DE, Comeau MR, et al. Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol. 2007;179(4):2051–2054.
   PubMed Web of Science ®Google Scholar
• Hawrylowicz CM, O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol. 2005;5(4):271.
   PubMed Web of Science ®Google Scholar
• Raeiszadeh Jahromi S, Mahesh PA, Jayaraj BS, et al. Serum levels of IL-10, IL-17F and IL-33 in patients with asthma: a case-control study. J Asthma. 2014;51(10):1004–1013.
   PubMed Web of Science ®Google Scholar
• Ebenezer AJ, Arunachalam P, Elden BT. H4R activation utilizes distinct signaling pathways for the production of RANTES and IL-13 in human mast cells. J Recept Signal Trans. 2017;37(2):133–140.
   PubMed Web of Science ®Google Scholar
• Ali K, Camps M, Pearce WP, et al. Isoform-specific functions of phosphoinositide 3-kinases: p110δ but not p110γ promotes optimal allergic responses in vivo. J Immunol. 2008;180(4):2538–2544.
   PubMed Web of Science ®Google Scholar
• Miller AM. Role of IL-33 in inflammation and disease. J Inflamm. 2011;8(1):22.
   Google Scholar
• Nagarajan G, Mariappanadar V, Tamizh M, et al. Effect of H4R antagonist N-(2-aminoethyl)-5-chloro-1H-indol-2-carboxamides and 5-chloro-2-(piperazin-1-ylmethyl)-1H-benzimidazole on histamine and 4-methylhistamine-induced mast cell response. J Recept Signal Trans. 2017;37(3):304–313.
   PubMed Web of Science ®Google Scholar